tegafur has been researched along with Glioma in 9 studies
Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Controlled, prospective, randomized studies were performed to evaluate the effects of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3- (2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) and ACNU plus tegafur as additions to radiotherapy for the treatment of malignant gliomas." | 9.05 | [Evaluation of ACNU alone and combined with tegafur as additions to radiotherapy of the treatment of malignant gliomas--a cooperative clinical trial]. ( Abe, H; Kitamura, K; Matsutani, M; Miwa, T; Nomura, K; Suzuki, J; Takakura, K; Takeuchi, K; Tanaka, R; Ushio, Y, 1985) |
| " Conventional, external radiotherapy (180-200 cGy/5 fractions/week) using 60Co or a 10 MV linear accelerator was given in conjunction with chemotherapy of nimustine hydrochloride (ACNU) and tegafur (FT-207) in eight patients with gliomas." | 7.67 | [Radiochemotherapy-related changes in the brain parenchyma of glioma patients evaluated repeatedly by C15O2, C15O, 15O2, and 18F-fluorodeoxyglucose (FDG) PET]. ( Kowada, M; Mineura, K; Ogawa, T; Sasajima, T; Shishido, F; Suda, Y; Uemura, K, 1989) |
| "Controlled, prospective, randomized studies were performed to evaluate the effects of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3- (2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) and ACNU plus tegafur as additions to radiotherapy for the treatment of malignant gliomas." | 5.05 | [Evaluation of ACNU alone and combined with tegafur as additions to radiotherapy of the treatment of malignant gliomas--a cooperative clinical trial]. ( Abe, H; Kitamura, K; Matsutani, M; Miwa, T; Nomura, K; Suzuki, J; Takakura, K; Takeuchi, K; Tanaka, R; Ushio, Y, 1985) |
| " Conventional, external radiotherapy (180-200 cGy/5 fractions/week) using 60Co or a 10 MV linear accelerator was given in conjunction with chemotherapy of nimustine hydrochloride (ACNU) and tegafur (FT-207) in eight patients with gliomas." | 3.67 | [Radiochemotherapy-related changes in the brain parenchyma of glioma patients evaluated repeatedly by C15O2, C15O, 15O2, and 18F-fluorodeoxyglucose (FDG) PET]. ( Kowada, M; Mineura, K; Ogawa, T; Sasajima, T; Shishido, F; Suda, Y; Uemura, K, 1989) |
| "Haemocirculatory and metabolic changes in seemingly normal brain tissue following radiochemotherapy including nimustine hydrochloride (ACNU) and tegafur (FT) were analyzed using oxygen-15 and fluorine-18 positron emission tomography (PET) in seven patients with gliomas." | 3.67 | Early and late stage positron emission tomography (PET) studies on the haemocirculation and metabolism of seemingly normal brain tissue in patients with gliomas following radiochemotherapy. ( Kowada, M; Mineura, K; Ogawa, T; Shishido, F; Suda, Y; Uemura, K; Yasuda, T, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsuchida, T | 1 |
| Watanabe, E | 1 |
| Nakayama, H | 1 |
| Sasaki, A | 1 |
| Nakamura, S | 1 |
| Sasaki, M | 1 |
| Fujiwara, T | 1 |
| Nemoto, S | 1 |
| Fujiwara, K | 1 |
| Yanagibashi, K | 1 |
| Hayakawa, I | 1 |
| Nomura, K | 2 |
| Harada, K | 1 |
| Okamoto, H | 1 |
| Kiya, K | 1 |
| Fujioka, Y | 1 |
| Uozumi, T | 1 |
| Kodama, Y | 1 |
| Mori, T | 1 |
| Fukawa, O | 1 |
| Sato, T | 1 |
| Hori, S | 1 |
| Tomura, N | 1 |
| Kato, T | 1 |
| Ogawa, T | 3 |
| Kanno, I | 1 |
| Shishido, F | 3 |
| Inugami, A | 1 |
| Fujita, H | 1 |
| Higano, S | 1 |
| Murakami, M | 1 |
| Uemura, K | 3 |
| Wakisaka, S | 2 |
| Shimauchi, M | 2 |
| Kaji, Y | 2 |
| Nonaka, A | 2 |
| Kinoshita, K | 2 |
| Mineura, K | 2 |
| Suda, Y | 2 |
| Sasajima, T | 1 |
| Kowada, M | 2 |
| Ushio, Y | 1 |
| Abe, H | 1 |
| Suzuki, J | 1 |
| Tanaka, R | 1 |
| Kitamura, K | 1 |
| Miwa, T | 1 |
| Matsutani, M | 1 |
| Takeuchi, K | 1 |
| Takakura, K | 1 |
| Maruoka, N | 1 |
| Moriyama, T | 1 |
| Oyama, H | 1 |
| Goya, T | 1 |
| Kodama, T | 1 |
| Yasuda, T | 1 |
1 trial available for tegafur and Glioma
| Article | Year |
|---|---|
[Evaluation of ACNU alone and combined with tegafur as additions to radiotherapy of the treatment of malignant gliomas--a cooperative clinical trial].
Topics: Adolescent; Adult; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Cli | 1985 |
8 other studies available for tegafur and Glioma
| Article | Year |
|---|---|
[FAR therapy in brain tumors--FT207-vitamin A-Radiation therapy (author's transl)].
Topics: Adolescent; Adult; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Drug Therapy, Combination; | 1980 |
[Pharmacokinetics study of UFT in malignant brain tumor patients].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; | 1983 |
[Regression of a recurrent malignant glioma by combined chemoradiotherapy utilizing carboquone, FT-207 and telecobalt--report of a case (author's transl)].
Topics: Azirines; Brain Neoplasms; Carbazilquinone; Cobalt Radioisotopes; Drug Therapy, Combination; Fluorou | 1977 |
[The changes of cerebral blood flow and metabolism of normal brain tissue after surgery, radiation, and chemotherapy in brain tumor patients: evaluated by position emission tomography].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Cerebrova | 1990 |
Acute phenytoin intoxication associated with the antineoplastic agent UFT.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; D | 1990 |
[Radiochemotherapy-related changes in the brain parenchyma of glioma patients evaluated repeatedly by C15O2, C15O, 15O2, and 18F-fluorodeoxyglucose (FDG) PET].
Topics: Adolescent; Adult; Antineoplastic Agents; Brain; Brain Neoplasms; Carbon Radioisotopes; Cerebrovascu | 1989 |
[AUFRAP therapy: combined modality treatment of malignant gliomas with intraarterial infusion of ACNU].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carotid Artery, Internal; Co | 1988 |
Early and late stage positron emission tomography (PET) studies on the haemocirculation and metabolism of seemingly normal brain tissue in patients with gliomas following radiochemotherapy.
Topics: Adolescent; Adult; Brain; Brain Neoplasms; Cerebrovascular Circulation; Child; Combined Modality The | 1988 |